Cargando…

Upregulation of ECT2 Predicts Adverse Clinical Outcomes and Increases 5-Fluorouracil Resistance in Gastric Cancer Patients

BACKGROUND: The abnormal expression and prognosis prediction of epithelial cell transforming sequence 2 (ECT2) in gastric cancer (GC) has been reported. However, the effect of ECT2 on 5-fluorouracil (5-Fu) resistance in GC is unclear. This research aims to solve the abovementioned problems. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hua, Geng, Yuan, Sun, Chunhui, Yu, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337122/ https://www.ncbi.nlm.nih.gov/pubmed/34367280 http://dx.doi.org/10.1155/2021/2102890

Ejemplares similares

PLOD2 increases resistance of gastric cancer cells to 5-fluorouracil by upregulating BCRP and inhibiting apoptosis
por: Wang, Xiaohui, et al.
Publicado: (2020)

Upregulation of ECT2 is associated with transcriptional program of cancer stem cells and predicts poor clinical outcome in gastric cancer
por: Gong, Dao-Yin, et al.
Publicado: (2020)

Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
por: Nakamura, Ayako, et al.
Publicado: (2013)

ECT IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Jagadisha,, et al.
Publicado: (2003)

MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway
por: Qin, Yannan, et al.
Publicado: (2022)

Does ECT Work? the Impact of ECT on Depression
por: Collins, Dawn
Publicado: (2023)

Fronto-Temporal Connectivity Predicts ECT Outcome in Major Depression
por: Leaver, Amber M., et al.
Publicado: (2018)

THE PRACTICE OF ECT IN INDIA: II. THE PRACTICAL ADMINISTRATION OF ECT
por: Andrade, Chittaranjan, et al.
Publicado: (1993)

S-1 and 5-Fluorouracil-related adverse events in patients with advanced gastric cancer: A meta-analysis
por: Hu, Qingqing, et al.
Publicado: (2023)

Increased expression of ECT2 predicts the poor prognosis of breast cancer patients
por: Yi, Ming, et al.
Publicado: (2022)

Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells
por: Kang, Kyoung Ah, et al.
Publicado: (2016)

Predictive signature of static and dynamic functional connectivity for ECT clinical outcomes
por: Fu, Zening, et al.
Publicado: (2023)

REEVALUATION OF ECT
por: Abhyankar, Ravi
Publicado: (1985)

ECT Transport
por: Serge Pelletier, et al.
Publicado: (2007)

Up-regulation of KLF17 expression increases the sensitivity of gastric cancer to 5-fluorouracil
por: An, Zhao-jie, et al.
Publicado: (2021)

Melatonin Potentiates Sensitivity to 5-Fluorouracil in Gastric Cancer Cells by Upregulating Autophagy and Downregulating Myosin Light-Chain Kinase
por: Shi, Xiaorui, et al.
Publicado: (2023)

Combination of ECT and clozapine in drug-resistant schizophrenia
por: Kurian, S., et al.
Publicado: (2005)

Effectiveness of Bifrontal ECT in Practice: A Comparison with Bitemporal ECT
por: Viswanath, Biju, et al.
Publicado: (2011)

THE PRACTICE OF ECT IN INDIA : ISSUES RELATING YO THE ADMINISTRATION OF ECT
por: Agarwal, A.K., et al.
Publicado: (1992)

SEIZURE DURATION OVER ECT SESSIONS: INFLUENCE OF SPACING ECTS
por: Janakiramaiah, N., et al.
Publicado: (1992)

A review of ketamine’s role in ECT and non-ECT settings
por: Jankauskas, Vytautas, et al.
Publicado: (2018)

ECT9 condensates with ECT1 and regulates plant immunity
por: Wang, Hui, et al.
Publicado: (2023)

EIF3D promotes resistance to 5‐fluorouracil in colorectal cancer through upregulating RUVBL1
por: Li, Chaobin, et al.
Publicado: (2023)

Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil()
por: Liu, Tong, et al.
Publicado: (2019)

5-Fluorouracil Conversion Pathway Mutations in Gastric Cancer
por: Biagioni, Alessio, et al.
Publicado: (2020)

Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil
por: SASADA, SHINSUKE, et al.
Publicado: (2012)

Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)
por: Trevithick, Liam, et al.
Publicado: (2015)

Suicidal ideation and ECT, ECT and suicidal ideation: A register study
por: Sienaert, Pascal, et al.
Publicado: (2022)

LncRNA PVT1 Mediates Antiapoptosis and 5-Fluorouracil Resistance via Increasing Bcl2 Expression in Gastric Cancer
por: Du, Peizhun, et al.
Publicado: (2019)

A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer
por: Wang, Qinchuan, et al.
Publicado: (2020)

Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-Fluorouracil
por: Yang, Hao, et al.
Publicado: (2021)

ECT AND PLATELET 5HT UPTAKE IN MAJOR DEPRESSION
por: Dalal, P.K., et al.
Publicado: (1997)

Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2(+) Breast Cancer Cells to 5-Fluorouracil
por: Yi, Jianing, et al.
Publicado: (2020)

Hadronic Atoms ECT
por: Gasser, J, et al.
Publicado: (2004)

CARDIOVASCULAR EFFECTS OF ECT
por: Chaudhury, Suprakash, et al.
Publicado: (2001)

ECT IN NEUROLOGICAL COUNDITIONS
por: Girish, K., et al.
Publicado: (2002)

PRACTICE OF ECT IN INDIA
por: Trivedi, J.K.
Publicado: (2002)

Role of ECT in Schizophrenia
por: Chopra, H.D.
Publicado: (1986)

Althesin in modified ECT
por: Andrade, Chittaranjan, et al.
Publicado: (1990)

UNILATERAL ECT AND DOSING
por: Andrade, Chittaranjan
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_26tsvr7442iehnri1qmjir7g0e